Osaic Holdings
MDGL icon

Osaic Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History

Osaic Holdings’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.11M Buy
4,040
+990
+32% +$473K ﹤0.01% 2025
2025
Q4 		$1.78M Buy
3,050
+2,248
+280% +$1.15M ﹤0.01% 2182
2025
Q3 		$362K Sell
802
-7,866
-91% -$2.93M ﹤0.01% 3704
2025
Q2 		$2.63M Buy
8,668
+7,933
+1,079% +$2.36M ﹤0.01% 1686
2025
Q1 		$243K Sell
735
-1,889
-72% -$621K ﹤0.01% 3474
2024
Q4 		$810K Buy
2,624
+470
+22% +$132K ﹤0.01% 2374
2024
Q3 		$457K Buy
2,154
+736
+52% +$188K ﹤0.01% 2956
2024
Q2 		$397K Buy
1,418
+230
+19% +$54.8K ﹤0.01% 2960
2024
Q1 		$317K Sell
1,188
-93
-7% -$21.9K ﹤0.01% 3295
2023
Q4 		$296K Sell
1,281
-195
-13% -$34.1K ﹤0.01% 3615
2023
Q3 		$216K Buy
1,476
+1,143
+343% +$215K ﹤0.01% 3937
2023
Q2 		$76.9K Buy
333
+77
+30% +$20.9K ﹤0.01% 4647
2023
Q1 		$62K Sell
256
-256
-50% -$69.8K ﹤0.01% 4805
2022
Q4 		$149K Sell
512
-465
-48% -$45.5K ﹤0.01% 4109
2022
Q3 		$64K Sell
977
-11
-1% -$764 ﹤0.01% 4713
2022
Q2 		$71K Sell
988
-50
-5% -$3.67K ﹤0.01% 4680
2022
Q1 		$102K Buy
1,038
+103
+11% +$8.68K ﹤0.01% 4583
2021
Q4 		$78K Buy
935
+69
+8% +$5.67K ﹤0.01% 4790
2021
Q3 		$70K Buy
866
+560
+183% +$48.4K ﹤0.01% 4837
2021
Q2 		$30K Buy
306
+45
+17% +$5.33K ﹤0.01% 5402
2021
Q1 		$30K Sell
261
-63
-19% -$7.34K ﹤0.01% 5227
2020
Q4 		$36K Buy
324
+186
+135% +$22.7K ﹤0.01% 4786
2020
Q3 		$16K Buy
138
+38
+38% +$4.13K ﹤0.01% 5030
2020
Q2 		$11K Sell
100
-423
-81% -$41.6K ﹤0.01% 5138
2020
Q1 		$35K Buy
+523
New +$43.6K ﹤0.01% 4255

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings's MDGL Position: Q1 2026 in Review

Osaic Holdings increased its Madrigal Pharmaceuticals (MDGL) stake by 32% in Q1 2026, buying an estimated $473K and bringing the position to 4,040 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2025.

Osaic Holdings first reported a position in MDGL in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.63M in Q2 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Osaic Holdings held 4,040 shares of Madrigal Pharmaceuticals worth $2.11M as of Q1 2026.
  • Osaic Holdings bought 990 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $473K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #2025 holding.
  • Osaic Holdings first reported a position in Madrigal Pharmaceuticals in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Madrigal Pharmaceuticals position peaked at $2.63M in Q2 2025.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.